Navigation Links
Experts Lay to Rest Long-Held Misconceptions About High Fructose Corn Syrup at ILSI-USDA Workshop
Date:4/27/2009

Corresponding Journal of Nutrition supplement urges health professionals to help reduce consumer confusion

WASHINGTON, April 27 /PRNewswire/ -- A supplement to be published in the June issue of the Journal of Nutrition encourages the scientific community and the general public to stop demonizing high fructose corn syrup as the culprit of obesity and to rethink the myths about high fructose corn syrup's impact on the American diet.

"The State of the Science on Dietary Sweeteners Containing Fructose" is the scientific summary of a joint conference held in March 2008 by the International Life Sciences Institute of North America and the U.S. Department of Agriculture, Agricultural Research Service. Several scientific papers from the supplement are currently available online.

The conference brought together several scientific leaders from varying backgrounds, including former critics of high fructose corn syrup, who found there is little evidence that high fructose corn syrup and sugar (or sucrose) have differing effects on satiety, overall energy balance, metabolic hormones or biochemical metabolites such as triglycerides and uric acid - all suggesting no unique causal role for high fructose corn syrup in obesity.

According to Suzanne P. Murphy, Ph.D., R.D., research professor at the Cancer Research Center of Hawaii, University of Hawaii, noted in her summary of the presented papers, "...[high fructose corn syrup] and sucrose are similar and one is not 'better or worse' than the other."

Dr. Murphy notes that "it does not appear to be practical to base dietary guidance on selecting or avoiding these specific types of sweeteners."

High Fructose Corn Syrup Is Not the Same as Fructose

Confusion about high fructose corn syrup has been fueled in part by erroneous links to research testing high levels of pure fructose,
'/>"/>

SOURCE Corn Refiners Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Global health experts release new guidance on malaria elimination
2. For ST-Elevation Myocardial Infarction (STEMI), Interviewed Experts Indicate That The Medicines Companys Angiomax/Angiox Has Efficacy Advantages Over Sales-Leading ReoPro
3. Media Advisory: PHR Experts Available to Comment on Torture
4. Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer
5. PAREXEL Experts to Address Partnering Best Practices and Innovative Trial Design at Partnerships With CROs Conference
6. Beauty-Doctors Website Provides Dermatologist-Authored Skin Care Information from Experts
7. For Atrial Fibrillation, Surveyed Experts Indicate That Multaq, Celivarone and ATI-2042 Have Advantages Over Propafenone in the Maintenance of Normal Sinus Rhythm
8. Experts Highlight Inroads to Preventing Cancer
9. PRA International to Present Key Challenges for Safety Professionals at the World Drug Safety Congress: PRA Experts discussing REMS at Washington DC Conference
10. For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission
11. National Health Experts Launch Bipartisan Coalition to Fight Chronic Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2015)... 02, 2015 As a nonsurgical ... of the face, neck and décolleté, radiofrequency energy ... real potential for the success of vulvovaginal rejuvenation. ... Clinical Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory ... concluded that ThermiGyn’s temperature controlled radio frequency, specifically ...
(Date:5/2/2015)... success that Veatch Dental Consulting has had over the years, ... Shields to the team. With Neida and Alex on board, ... working with dentists to ensure their success. , Neida Miranda ... She was certified as dental assistant from Texas State Technical ... the importance of oral hygiene to patients, Neida was moved ...
(Date:5/1/2015)... May 02, 2015 The Venetian on ... http://www.thevenetiangracebay.com , and it is elegant and sophisticated, ... white and attractive turquoise hues of Grace Bay Beach. ... seven percent of leisure travelers used their smartphones throughout ... were used in the planning and researching and continued ...
(Date:5/1/2015)... Anaheim, CA (PRWEB) May 01, 2015 ... Ethos Award for the successful repositioning of its flagship ... its company brand with a new name, new logo, ... The DSA Ethos Awards are designed to identify and ... at its best. , “DSA congratulates Jusuru International ...
(Date:5/1/2015)... RESTON, Va. (PRWEB) May 01, 2015 ... the nation’s leading nonprofit authority on the use of ... served as a key contributing resource to the United ... the use of electronically readable cards in Medicare. The ... Beneficiaries and Providers ” was released to the public ...
Breaking Medicine News(10 mins):Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3
... Presentation to highlight milestones including phase III development of ... What: Horizon Therapeutics, Inc. is pleased to announce that ... M.D., Ph.D., chief executive officer, will ... including its recent completion of Series C financing, and ...
... Twelve of Sixteen FH Patients in an Ongoing Open-Label Extension Study,Have Been Dosed With ... Four Have Been Dosed for More Than ... 8:00 a.m. E.T. ... at http://www.isispharm.com , CARLSBAD, Calif., Oct. 5 Isis,Pharmaceuticals, Inc. (Nasdaq: ...
... knows about the,FDA,s impending ban on children,s cold ... scramble to find other ways to alleviate their ... recently,introduced into the U.S. -- offers a safe ... According to the FDA, popular medicines such ...
... SOUTH SAN FRANCISCO, Calif., Oct. 4 Sunesis,Pharmaceuticals, Inc. ... inducement stock options awards in accordance with NASDAQ,Marketplace Rule ... stock options cover an aggregate of 48,000 shares of,common ... an,exercise price equal to the fair market value of ...
... U.S. may,be breathing its last gasps, as the ... Passage in the House is expected to be ... past six years, this legislation would,finally ban asbestos, ... asbestos, most deadly cancer, mesothelioma (meso), and other,asbestos-related ...
... IRIDEX,Corporation (Nasdaq: IRIX ) announced the appointment ... Company,s new independent auditor effective October,2, 2007. BPM, ... the Audit Committee of the Company,s Board of ... with several,public accounting firms. BPM replaces PricewaterhouseCoopers LLP. ...
Cached Medicine News:Health News:Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting 2Health News:Isis Reports That ISIS 301012 is Well Tolerated in Patients Treated for Five Or More Months 2Health News:Isis Reports That ISIS 301012 is Well Tolerated in Patients Treated for Five Or More Months 3Health News:Isis Reports That ISIS 301012 is Well Tolerated in Patients Treated for Five Or More Months 4Health News:Isis Reports That ISIS 301012 is Well Tolerated in Patients Treated for Five Or More Months 5Health News:Nosefrida Nasal Aspirator - A Parent's Alternative to Medicines on the Verge of FDA Ban 2Health News:Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350 2Health News:Asbestos No More: Historic Asbestos Ban Passage Imminent 2Health News:Asbestos No More: Historic Asbestos Ban Passage Imminent 3Health News:Asbestos No More: Historic Asbestos Ban Passage Imminent 4
(Date:5/1/2015)... May 01, 2015 Research and Markets ( ... Dermatology Devices Market by Type, by End User - Forecast ... Asian Dermatology Devices market is estimated to grow at a ... holds a larger share in the Dermatology devices ... . The Asian Dermatology Devices market holds a high ...
(Date:5/1/2015)... Colo. , May 1, 2015   Heska Corporation ... or the "Company"), a provider of advanced veterinary diagnostic ... Robert Grieve , Executive Chair, will present at the 16th ... (PT), on May 13, 2015. The conference will be held ... Angeles, CA. Heska management will be available during ...
(Date:5/1/2015)... 2015  CytRx Corporation (CYTR), a biopharmaceutical research ... financial results for the three months ended March ... accomplishments and upcoming milestones for its clinical development ... the early months of 2015, including the announcement ... aldoxorubicin in patients with soft tissue sarcoma, and ...
Breaking Medicine Technology:Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11
... , SAN DIEGO , Feb. 2 ADVENTRX ... Principal Executive Officer, Brian M. Culley , will present at the ... 2010 , at 10:30 a.m. Eastern time , in the Park ... conference is being hosted by the Biotechnology Industry Association. , Interested parties ...
... , , ... February 2 ReportsandReports announce to,have Biosimilars Series: Forecast ... The high cost and utilization of ... provides considerable momentum to,the emerging biosimilars market. With a biosimilar ...
Cached Medicine Technology:ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9 2ReportsandReports: Biosimilars Series - Forecast Analysis Market Research Report 2ReportsandReports: Biosimilars Series - Forecast Analysis Market Research Report 3
Intermittent catheter...
Intermittent catheter...
... new Finnpipette Focus from Thermo Labsystems was ... performance. Advanced features such as the ... volume adjustment on microvolumes help to define ... channel pipettes. The new interchangeable handle plate ...
Disease diagnosis and treatment reference sourced from Griffith's 5-Minute Clinical Consult. Save time diagnosing and treating more than 1,200 diseases and conditions....
Medicine Products: